Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000535244 | SCV000639464 | pathogenic | Developmental and epileptic encephalopathy, 2; Angelman syndrome-like | 2019-07-18 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln507*) in the CDKL5 gene. It is expected to result in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with CDKL5-related disease. ClinVar contains an entry for this variant (Variation ID: 464809). Loss-of-function variants in CDKL5 are known to be pathogenic (PMID: 22872100). For these reasons, this variant has been classified as Pathogenic. |
Pediatric Department, |
RCV003326138 | SCV004032230 | pathogenic | Developmental and epileptic encephalopathy, 2 | no assertion criteria provided | research |